March 11, 2025 01:39 PM EDTUpdated 04:22 PM

Merck scores a win in Gardasil cases after judge says plaintiffs’ evidence ‘falls far short’

Nicole DeFeudis

Editor

Merck convinced a federal judge to toss claims alleging that it failed to properly warn patients of potential risks related to its Gardasil HPV vaccine …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Merck scores a win in Gardasil cases after judge says plaintiffs’ evidence ‘falls far short’

Nicole DeFeudis

Editor

Sign up to read this article for free.

Vice President, Biology & Translational Research

Gondolabio

Palo Alto, CA, USA

Updated: Zealand partners with Roche on its amylin analog in a deal worth up to $5.3B

Ono licenses rare blood disease drug from Ionis for $280M upfront

Legend to double Carvykti production as it targets blockbuster status

FDA’s medical review departments remain untouched (for now) by Musk’s cuts

Arvinas, Pfizer’s PROTAC data fall short of hype in breast cancer

Obesity drug development—still room to grow

Mer­ck scores a win in Gar­dasil cas­es af­ter judge says plain­tiffs’ ev­i­dence ‘falls far short’

Editor

Sign up to read this article for free.

Gondolabio

Palo Alto, CA, USA

Merck scores a win in Gardasil cases after judge says plaintiffs’ evidence ‘falls far short’